Immunotherapy Today

Immunotherapy News From Around The World

Immunotherapy could stop prostate cancer spreading, trial shows

Posted by btwatson on June 3, 2018 1:45 am
Tags:
Categories: Uncategorized

Source: Immunotherapy could stop prostate cancer spreading, trial shows

[unable to retrieve full-text content]

  1. Immunotherapy could stop prostate cancer spreading, trial shows  The Guardian
  2. Immunotherapy prostate cancer drug gives ‘amazing results’  Sky News
  3. Men with advanced prostate cancer could benefit from ‘amazing’ immunotherapy trial  ITV News
  4. Full coverage

Published at Sat, 02 Jun 2018 17:51:00 +0000

< Immunotherapy Today home

Immunotherapy News

  • Immunotherapy Advances in SCLC Highlight Promise, Limitations, and Biomarker Needs - OncLive
    November 15, 2025
  • Dr Bhora on How Perioperative Immunotherapy Is Reshaping the Treatment Paradigm in Resectable NSCLC - OncLive
    November 15, 2025
  • C. Ola Landgren: Successful Myeloma Immunotherapy Preceptorship at Sylvester Myeloma Institute - Oncodaily
    November 15, 2025
  • Biomimetic mRNA Delivery System Enhances Targeted Immunotherapy for Colorectal Cancer - BIOENGINEER.ORG
    November 15, 2025
  • TKIs Take Lead After Immunotherapy in Metastatic Kidney Cancer - Cure Today
    November 14, 2025
  • Why Cancer Care Needs a "Both/And" Approach - Targeted Oncology
    November 14, 2025
  • Cancer Immunotherapy: Basic Mechanisms Informing Clinical Applications and Combinations - Oncodaily
    November 14, 2025
  • Gertjan Rasschaert: The Dawn of Immunotherapy in Mismatch Repair Proficient Colorectal Cancer - Oncodaily
    November 14, 2025
  • Comprehensive analysis of ALYREF gene expression and its correlation with immunotherapy efficacy and circulating tumor cells in bladder cancer - Nature
    November 14, 2025
  • The latest chemo-immunotherapy model for heterogeneous tumors - EurekAlert!
    November 14, 2025

Immunotherapy News from China

  • UPDATE 2-U.S. FDA approves Merck immunotherapy/chemo combo …
  • …Announces Off-the-Shelf CAR T-cell Cancer Immunotherapy to…
  • UPDATE 2-U.S. FDA approves Merck immunotherapy/chemo combo …
  • …in Combination With Anti-PD-L1 Cancer Immunotherapy and …
  • …Dosed in First-in-Human Clinical Study of Immunotherapy …
  • JITC tumor and cancer immunotherapy papers collection
    JITC tumor and cancer immunotherapy papers collection
  • Welcome to the submission|Journal for ImmunoTherapy of Cancer
  • Immunotherapy shows promise for advanced lymphoma: study
  • …from the Monotherapy Arm at the Phacilitate Immunotherapy …
  • Allergy Immunotherapy Market to exceed US$ 3.33 Bn by 2025 …
  • Load more [+]

Copyright 2018 ImmunoTherapyToday.com